An AI-guided signature reveals the nature of the shared proximal pathways of host immune response in MIS-C and Kawasaki disease
D. Sahoo, G. Dattatray, C. Shimizu, J. Kim, S. Khandelwal, A. H. Tremoulet, J. Kanegaye, Pediatric Emergency Medicine Kawasaki Disease Research Group, J. Bocchini, S. Das, J. C. Burns, P. Ghosh
Abstract
A significant surge in cases of multisystem inflammatory syndrome in children (MIS-C, also called Pediatric Inflammatory Multisystem Syndrome - PIMS) has been observed amidst the COVID-19 pandemic. MIS-C shares many clinical features with Kawasaki disease (KD), although clinical course and outcomes are divergent. We analyzed whole blood RNA sequences, serum cytokines, and formalin fixed heart tissues from these patients using a computational toolbox of two gene signatures, i.e., the 166-gene viral pandemic (ViP) signature, and its 20-gene severe (s)ViP subset that were developed in the context of SARS-CoV-2 infection and a 13-transcript signature previously demonstrated to be diagnostic for KD. Our analyses revealed that KD and MIS-C are on the same continuum of the host immune response as COVID-19. While both the pediatric syndromes converge upon an IL15/IL15RA-centric cytokine storm, suggestive of shared proximal pathways of immunopathogenesis, they diverge in other laboratory parameters and cardiac phenotypes. The ViP signatures also revealed unique targetable cytokine pathways in MIS-C, place MIS-C farther along in the spectrum in severity compared to KD and pinpoint key clinical (reduced cardiac function) and laboratory (thrombocytopenia and eosinopenia) parameters that can be useful to monitor severity.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Description and comparison of PIMS-TS innate cell signature and immunophenotype with a cohort of healthy children, severe viral and bacterial infections and Kawasaki Disease.
A. Garcia-Salido, I. Leoz-Gordillo, … M. Nieto-Moro·bioRxiv·Mar 29, 2021
- A monocyte/dendritic cell molecular signature of SARS-CoV2-related multisystem inflammatory syndrome in children (MIS-C) with severe myocarditis
C. de Cevins, M. Luka, … Gras Leguen·MedPeer-reviewed·Sep 1, 2021
- Age-Associated Weaker Immunity to Coronaviruses is Characteristic of Children that Develop Multisystem Inflammatory Syndrome following SARS-CoV-2 Infection
D. Camerini, A. Arrieta, … D. Nugent·bioRxiv·Aug 28, 2023
- Establishing thresholds for cytokine storm and defining their relationship to disease severity in respiratory viral infections
A. Souquette, J. C. Crawford, … P. G. Thomas·bioRxiv·Jul 6, 2023
- Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
B. P. Boribong, T. J. LaSalle, … L. M. Yonker·bioRxiv·Dec 18, 2021
- A distinct innate immune signature marks progression from mild to severe COVID-19
S. Chevrier, Y. Zurbuchen, … B. Bodenmiller·bioRxiv·Aug 4, 2020